Avid Bioservices Inc.

24.83-0.2600-1.04%Vol 171.44K1Y Perf 262.74%
Jul 27th, 2021 13:16 DELAYED
BID24.78 ASK24.84
Open24.90 Previous Close25.09
Pre-Market- After-Market-
 - -%  - -
Target Price
27.50 
Analyst Rating
Strong Buy 1.00
Potential %
10.62 
Finscreener Ranking
★+     44.41
Insiders Trans % 3/6/12 mo.
-100/-71/-71 
Value Ranking
+     38.01
Insiders Value % 3/6/12 mo.
-100/-7/-7 
Growth Ranking
★★★+     55.79
Insiders Shares Cnt. % 3/6/12 mo.
-100/-5/-5 
Income Ranking
 —    -
Market Cap1.52B 
Earnings Rating
Neutral
Price Range Ratio 52W %
89.33 
Earnings Date
7th Sep 2021

Today's Price Range

24.4525.25

52W Range

6.4927.02

5 Year PE Ratio Range

-18.80-2.80

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-1.95%
1 Month
-0.04%
3 Months
16.32%
6 Months
79.86%
1 Year
262.74%
3 Years
358.68%
5 Years
868.73%
10 Years
110.84%

TickerPriceChg.Chg.%
CDMO24.83-0.2600-1.04
AAPL146.05-2.9400-1.97
GOOG2 710.08-82.8100-2.97
MSFT284.07-4.9800-1.72
XOM57.59-0.8900-1.52
WFC45.080.07000.16
JNJ172.390.52000.30
FB365.74-6.7200-1.80
GE13.060.14001.08
JPM151.700.05000.03
Financial StrengthValueIndustryS&P 500US Markets
2.70
2.90
0.60
1.52
10.60
Leverage Ratio 2.50
ProfitabilityValueIndustryS&P 500US Markets
30.60
12.90
16.50
-10.30
11.74
RevenueValueIndustryS&P 500US Markets
95.87M
1.57
20.33
11.86
Earnings HistoryEstimateReportedSurprise %
Q04 20210.00-0.04-
Q03 2021-0.020.01150.00
Q02 2021-0.050.01120.00
Q01 2021-0.06-
Q04 2020-0.16-0.1131.25
Q03 2020-0.03-0.06-100.00
Q02 2020-0.04-0.0325.00
Q01 2020-0.03-0.08-166.67
Earnings Per EndEstimateRevision %Trend
7/2021 QR0.020.00-
10/2021 QR0.030.00-
4/2022 FY0.19-5.00Negative
4/2023 FY0.400.00-
Next Report Date7th Sep 2021
Estimated EPS Next Report0.02
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume171.44K
Shares Outstanding61.10M
Trades Count2.29K
Dollar Volume14.03M
Avg. Volume672.56K
Avg. Weekly Volume409.33K
Avg. Monthly Volume629.98K
Avg. Quarterly Volume582.51K

Avid Bioservices Inc. (NASDAQ: CDMO) stock closed at 25.09 per share at the end of the most recent trading day (a -3.28% change compared to the prior day closing price) with a volume of 354.01K shares and market capitalization of 1.52B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 227 people. Avid Bioservices Inc. CEO is Nicholas S. Green.

The one-year performance of Avid Bioservices Inc. stock is 262.74%, while year-to-date (YTD) performance is 117.42%. CDMO stock has a five-year performance of 868.73%. Its 52-week range is between 6.49 and 27.02, which gives CDMO stock a 52-week price range ratio of 89.33%

Avid Bioservices Inc. currently has a PE ratio of 648.50, a price-to-book (PB) ratio of 20.39, a price-to-sale (PS) ratio of 15.99, a price to cashflow ratio of 49.40, a PEG ratio of 2.32, a ROA of 1.73%, a ROC of -0.35% and a ROE of 5.36%. The company’s profit margin is 11.74%, its EBITDA margin is 16.50%, and its revenue ttm is $95.87 Million , which makes it $1.57 revenue per share.

Of the last four earnings reports from Avid Bioservices Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.02 for the next earnings report. Avid Bioservices Inc.’s next earnings report date is 07th Sep 2021.

The consensus rating of Wall Street analysts for Avid Bioservices Inc. is Strong Buy (1), with a target price of $27.5, which is +10.62% compared to the current price. The earnings rating for Avid Bioservices Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Avid Bioservices Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Avid Bioservices Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.81, ATR14 : 1.14, CCI20 : -33.81, Chaikin Money Flow : 0.10, MACD : 0.48, Money Flow Index : 42.03, ROC : -5.75, RSI : 50.36, STOCH (14,3) : 33.84, STOCH RSI : 0.00, UO : 45.05, Williams %R : -66.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Avid Bioservices Inc. in the last 12-months were: Daniel Ryan Hart (Option Excercise at a value of $0), Daniel Ryan Hart (Sold 5 409 shares of value $138 528 ), Mark R. Bamforth (Buy at a value of $2 290 680), Mark R. Bamforth (Sold 126 000 shares of value $2 290 680 ), Mark R. Ziebell (Option Excercise at a value of $0), Mark R. Ziebell (Sold 7 207 shares of value $184 574 ), Richard B. Hancock (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Avid Bioservices Inc.

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on development and current Good Manufacturing Practices (cGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development, high quality cGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

CEO: Nicholas S. Green

Telephone: +1 714 508-6100

Address: 2642 Michelle Drive, Tustin 92780, CA, US

Number of employees: 227

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

56%44%

Bearish Bullish

45%55%

News

Stocktwits